11![Access : Phase II Trial of Intravenous Administration of Reolysin|[reg]| (Reovirus Serotype-3-dearing Strain) in Patients with Access : Phase II Trial of Intravenous Administration of Reolysin|[reg]| (Reovirus Serotype-3-dearing Strain) in Patients with](https://www.pdfsearch.io/img/d27c4a5235c7d7818219006af96d20cd.jpg) | Add to Reading ListSource URL: www.oncolyticsbiotech.com- Date: 2013-12-23 11:07:27
|
---|
12![Print - Intravenous administration of Reolysin, a l... [Invest New Drugs[removed]PubMed - NCBI Print - Intravenous administration of Reolysin, a l... [Invest New Drugs[removed]PubMed - NCBI](https://www.pdfsearch.io/img/c45902479e81b3a6a6a3fe42e16a68e1.jpg) | Add to Reading ListSource URL: www.oncolyticsbiotech.com- Date: 2013-12-23 11:38:13
|
---|
13![© The American Society of Gene Therapy original article A Phase I Trial of Intratumoral Administration of Reovirus in Patients With Histologically Confirmed © The American Society of Gene Therapy original article A Phase I Trial of Intratumoral Administration of Reovirus in Patients With Histologically Confirmed](https://www.pdfsearch.io/img/6f59b637f58de600248c089a75557d6a.jpg) | Add to Reading ListSource URL: www.oncolyticsbiotech.comLanguage: English - Date: 2013-12-23 11:30:37
|
---|
14![Print - Systemic administration of reovirus (Reolysin) inhibi... [Cancer[removed]PubMed - NCBI Print - Systemic administration of reovirus (Reolysin) inhibi... [Cancer[removed]PubMed - NCBI](https://www.pdfsearch.io/img/4aa080f1278e0fa580b5b77324cec929.jpg) | Add to Reading ListSource URL: www.oncolyticsbiotech.com- Date: 2013-12-23 11:54:45
|
---|
15![Heinemann et al. BMC Cancer 2011, 11:221 http://www.biomedcentral.com[removed] RESEARCH ARTICLE Open Access Heinemann et al. BMC Cancer 2011, 11:221 http://www.biomedcentral.com[removed] RESEARCH ARTICLE Open Access](https://www.pdfsearch.io/img/85401678d7ccfffd6d1cdc9e2d494787.jpg) | Add to Reading ListSource URL: www.oncolyticsbiotech.comLanguage: English - Date: 2013-12-23 11:49:37
|
---|
16![Microsoft PowerPoint - Investor Presentation August[removed]Read-Only] Microsoft PowerPoint - Investor Presentation August[removed]Read-Only]](https://www.pdfsearch.io/img/514f107cf770697836bbe6bd45c2bea3.jpg) | Add to Reading ListSource URL: www.oncolyticsbiotech.comLanguage: English - Date: 2014-08-18 11:01:12
|
---|
17![PSIOXUS THERAPEUTICS RECEIVES £1.8 MILLION TRANSLATION AWARD FROM THE WELLCOME TRUST TO TAKE ONCOLYTIC VIRUS INTO CLINIC ColoAd1 will enter phase I/II development for metastatic colorectal cancer in 2012 LONDON –12 Se PSIOXUS THERAPEUTICS RECEIVES £1.8 MILLION TRANSLATION AWARD FROM THE WELLCOME TRUST TO TAKE ONCOLYTIC VIRUS INTO CLINIC ColoAd1 will enter phase I/II development for metastatic colorectal cancer in 2012 LONDON –12 Se](https://www.pdfsearch.io/img/18eb16d8f0035f75f1d99d28161604d4.jpg) | Add to Reading ListSource URL: www.psioxus.comLanguage: English - Date: 2011-12-20 03:27:39
|
---|
18![Microsoft PowerPoint - iSBTc_SanDiego_101 08 KJH - Final [Compatibility Mode] Microsoft PowerPoint - iSBTc_SanDiego_101 08 KJH - Final [Compatibility Mode]](https://www.pdfsearch.io/img/005afbeaa736c349fe69a44f67b656e8.jpg) | Add to Reading ListSource URL: media.integratir.comLanguage: English - Date: 2008-11-03 02:33:56
|
---|
19![](https://www.pdfsearch.io/img/d9f989a20dc2e399aea0bba797c94f1b.jpg) | Add to Reading ListSource URL: media.integratir.comLanguage: English - Date: 2009-11-17 08:44:53
|
---|